Impact of Class Ii Hla Mismatch on Clinical Outcomes in Hodgkin Lymphoma Patients Receiving Haploidentical Stem Cell Transplantation (Haplo-Sct) With Post-Transplant Cyclophosphamide (Pt-Cy)

Hematological Oncology - United Kingdom
doi 10.1002/hon.109_2630

Related search